Cetera Investment Advisers
DGX icon

Cetera Investment Advisers’s Quest Diagnostics DGX Stock Holding History

Cetera Investment Advisers’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.4M Buy
39,616
+2,342
+6% +$460K 0.01% 1262
2026
Q1 		$7.3M Buy
37,274
+8,362
+29% +$1.62M 0.01% 1265
2025
Q4 		$5.02M Sell
28,912
-391
-1% -$71.2K 0.01% 1460
2025
Q3 		$5.58M Buy
29,303
+5,462
+23% +$969K 0.01% 1337
2025
Q2 		$4.28M Buy
23,841
+835
+4% +$145K 0.01% 1290
2025
Q1 		$3.89M Buy
23,006
+4,607
+25% +$757K 0.01% 1276
2024
Q4 		$2.78M Buy
18,399
+1,462
+9% +$227K 0.01% 1414
2024
Q3 		$2.63M Buy
16,937
+812
+5% +$121K 0.01% 1409
2024
Q2 		$2.21M Buy
16,125
+243
+2% +$33.3K 0.01% 1491
2024
Q1 		$2.11M Buy
15,882
+12,154
+326% +$1.58M 0.01% 1505
2023
Q4 		$514K Sell
3,728
-1,283
-26% -$169K ﹤0.01% 1471
2023
Q3 		$611K Sell
5,011
-1,683
-25% -$224K 0.01% 1326
2023
Q2 		$941K Buy
6,694
+17
+0.3% +$2.34K 0.01% 1089
2023
Q1 		$945K Sell
6,677
-1,772
-21% -$254K 0.01% 1063
2022
Q4 		$1.32M Buy
8,449
+6,361
+305% +$914K 0.01% 873
2022
Q3 		$256K Sell
2,088
-1,494
-42% -$197K 0.01% 1373
2022
Q2 		$476K Sell
3,582
-32
-0.9% -$4.36K 0.01% 1128
2022
Q1 		$495K Sell
3,614
-4,232
-54% -$590K 0.01% 1165
2021
Q4 		$1.36M Sell
7,846
-1,107
-12% -$168K 0.02% 691
2021
Q3 		$1.3M Buy
8,953
+1,259
+16% +$184K 0.02% 681
2021
Q2 		$1.01M Buy
7,694
+151
+2% +$19.8K 0.02% 768
2021
Q1 		$968K Buy
7,543
+1,973
+35% +$243K 0.02% 683
2020
Q4 		$664K Buy
+5,570
New +$679K 0.01% 839

Other funds holding DGX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return

Cetera Investment Advisers's DGX Position: Q2 2026 in Review

Cetera Investment Advisers increased its Quest Diagnostics (DGX) stake by 6.3% in Q2 2026, buying an estimated $460K and bringing the position to 39,616 shares worth $8.4M. The position accounts for 0.01% of the portfolio, ranked #1262.

Cetera Investment Advisers first reported a position in DGX in Q4 2020 and has held it in 23 quarters since. 1,109 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

  • Cetera Investment Advisers held 39,616 shares of Quest Diagnostics worth $8.4M as of Q2 2026.
  • Cetera Investment Advisers bought 2,342 Quest Diagnostics shares in Q2 2026, an estimated $460K.
  • Quest Diagnostics made up 0.01% of Cetera Investment Advisers's portfolio in Q2 2026, its #1262 holding.
  • Cetera Investment Advisers first reported a position in Quest Diagnostics in Q4 2020 and has held it in 23 quarters since.
  • 1,109 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on Cetera Investment Advisers's 13F filing for Q2 2026, filed 12 Aug 2026.